Discover the principles behind Countable PCR, how it compares with established molecular quantification methods, and what direct RNA counting could mean for research and clinical applications.

A new research paper was published in Volume 13 of Oncoscience on February 7, 2026, titled “Reduced immunogenicity of MYC ...

All three patients enrolled in study have been cured, confirming high cure rate of tafenoquine in immunosuppressed patients, ...

Project demonstrates that a multiplex tNGS assay can function as a reliable and informative diagnostic tool.

MYC amplification is associated with reduced tumor immunogenicity as assessed by the recovery of IR recombination reads from prostate cancer genomics ...

A LAMP-based, visually read assay enables rapid FSHR N680S genotyping from buccal swabs, potentially allowing pre-cycle ...

Qiagen receives US FDA clearance for gastrointestinal panels on fully automated QIAstat-Dx Rise Syndromic Testing System: Frankfurt Friday, March 13, 2026, 11:00 Hrs [IST] Qiagen ...

Panels for use on the fully automated QIAstat-Dx Rise platform, marking the ninth U.S. QIAstat-Dx panel clearance in last 24 monthsLaboratories can now run respiratory and gastrointestinal panels, ...

The Michigan startup uses a proprietary approach called processor-mediated PCR to enable high-plex, low-cost testing in a ...

Based Platforms, Isothermal Amplification Technologies, and Lab-on-a-Chip Systems Accelerating Market Expansion Globally.Austin, United States, March 09, 2026 (GLOBE NEWSWIRE) -- Point-of-Care ...

US FDA accepts and grants priority review status to AstraZeneca and Daiichi Sankyo’s sBLA for Enhertu to treat adult patients with HER2-positive early breast cancer: Cambridge, ...